TScan Therapeutics, Inc. (TCRX)
NASDAQ·Healthcare·Biotechnology
$1.27
-3.44%
Mkt Cap $73.13M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $2.44M | $2.57M | +5.40% | -$0.27 | -$0.18 | +33.33% | — | — |
| Q4 2025 Nov 12, 2025 | $1.94M | $2.51M | +29.43% | -$0.35 | -$0.28 | +20.00% | — | — |
| Q3 2025 Aug 12, 2025 | $1.86M | $3.08M | +65.38% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q2 2025 May 6, 2025 | $1.08M | $2.17M | +100.09% | -$0.28 | -$0.26 | +7.14% | — | — |
| Q1 2025 Mar 5, 2025 | $1.52M | $665.00K | -56.24% | -$0.27 | -$0.29 | -7.41% | — | — |
| Q4 2024 Nov 12, 2024 | $1.17M | $1.05M | -10.54% | -$0.28 | -$0.25 | +10.71% | — | — |
| Q3 2024 Aug 12, 2024 | $1.80M | $536.00K | -70.22% | -$0.30 | -$0.28 | +6.67% | — | — |
| Q2 2024 May 13, 2024 | $3.98M | $566.00K | -85.76% | -$0.25 | -$0.32 | -28.00% | — | — |
| Q1 2024 Mar 6, 2024 | $3.45M | $7.21M | +108.77% | -$0.30 | -$0.21 | +30.00% | — | — |
| Q4 2023 Nov 9, 2023 | $4.45M | $3.89M | -12.66% | -$0.43 | -$0.24 | +44.19% | — | — |
| Q3 2023 Aug 10, 2023 | $4.37M | $3.15M | -28.03% | -$0.76 | -$0.51 | +32.89% | — | — |
| Q2 2023 May 10, 2023 | $4.87M | $6.80M | +39.72% | -$0.73 | -$0.93 | -27.40% | — | — |
| Q1 2023 Mar 8, 2023 | $4.10M | $1.00K | -99.98% | -$0.73 | -$0.78 | -6.85% | — | — |
| Q4 2022 Nov 9, 2022 | $3.93M | $3.36M | -14.43% | -$0.73 | -$0.67 | +8.22% | — | — |
| Q3 2022 Aug 10, 2022 | $3.00M | $4.06M | +35.03% | -$0.76 | -$0.63 | +17.11% | — | — |
| Q2 2022 May 9, 2022 | $2.76M | $3.02M | +9.64% | -$0.69 | -$0.67 | +2.90% | — | — |
| Q1 2022 Mar 9, 2022 | $3.47M | $2.85M | -17.67% | -$0.73 | -$0.38 | +47.95% | — | — |
| Q4 2021 Nov 10, 2021 | $6.70M | $2.41M | -64.02% | -$0.68 | -$0.80 | -17.65% | — | — |
| Q3 2021 Aug 19, 2021 | $2.43M | $2.85M | +17.20% | -$2.87 | -$7.69 | -167.94% | — | — |
| Q3 2021 Jul 15, 2021 | — | $2.03M | — | — | -$0.32 | — | — | — |